Sandu Pharmaceuticals Ltd.
| BSE: 524703 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE751D01014 |
| BSE 12:29 | 16 Apr | 33.60 |
-0.75 (-2.18%) |
OPEN
36.75 |
HIGH
36.75 |
LOW
30.05 |
| NSE 05:30 | 01 Jan | Sandu Pharmaceuticals Ltd |
| OPEN | 36.75 |
| PREVIOUS CLOSE | 34.35 |
| VOLUME | 4848 |
| 52-Week high | 43.70 |
| 52-Week low | 12.75 |
| P/E | 26.67 |
| Mkt Cap.(Rs cr) | 24 |
| Buy Price | 32.95 |
| Buy Qty | 128.00 |
| Sell Price | 33.60 |
| Sell Qty | 6.00 |
Sandu Pharmaceuticals Ltd. (SANDUPHARMA) - Announcements
-
Sandu Pharmaceuticals Ltd Compliance Certificate For Half Year Ended 31.03.2021
10/04/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09/04/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
05/04/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
01/04/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Allotment
31/03/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Allotment
30/03/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Closure of Trading Window
27/03/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Newspaper Publication Inrespect Of The Unaudited Financial Results For Q Ended 31St December 2020
16/02/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Financial Results For The Q Ended 31St December 2020
13/02/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Outcome Of The Board Meeting Dated 13Th February 2021
13/02/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Newspaper Publication For Intimation About The Board Meeting
02/02/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Board Meeting Intimation for Intimation Of The Board Meeting For The Approval Of Unaudited Financial
01/02/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended December 2020
19/01/2021 | bse
-
Sandu Pharmaceuticals Ltd Shareholding for the Period Ended December 31 2020
18/01/2021 | bse
-
Sandu Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
16/01/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08/01/2021 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Closure of Trading Window
24/12/2020 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
18/12/2020 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Clarification
03/12/2020 | bse |
Downlaod PDF -
Sandu Pharmaceuticals Ltd Clarification sought from Sandu Pharmaceuticals Ltd
01/12/2020 | bse
Quick Links for Sandu Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
